Cargando…

Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia

BACKGROUND: Elevated serum levels of growth differentiation factor-15 (GDF-15) are associated with type 2 diabetes. Therefore, the effects of atorvastatin on metabolic parameters and GDF-15 levels in patients with type 2 diabetes and dyslipidemia were evaluated. METHODS: In this prospective randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Min, Back, Min Kyung, Yi, Hyon-Seung, Joung, Kyong Hye, Kim, Hyun Jin, Ku, Bon Jeong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768053/ https://www.ncbi.nlm.nih.gov/pubmed/26616597 http://dx.doi.org/10.4093/dmj.2016.40.1.70

Ejemplares similares

Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Shin, Min Young, et al.
Publicado: (2016)

Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018)

A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2017)

Serum R-Spondin 1 Is a New Surrogate Marker for Obesity and Insulin Resistance
por: Kang, Yea Eun, et al.
Publicado: (2019)

Serum MIG6 concentration is increased by cholesterol-lowering treatment in patients with type 2 diabetes mellitus and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study
por: Joung, Kyong Hye, et al.
Publicado: (2020)

The Association between Type 2 Diabetes Mellitus and Women Cancer: The Epidemiological Evidences and Putative Mechanisms
por: Joung, Kyong Hye, et al.
Publicado: (2015)

Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus
por: Kim, Ji Min, et al.
Publicado: (2021)

Growth Differentiation Factor 15 Predicts Chronic Liver Disease Severity
por: Lee, Eaum Seok, et al.
Publicado: (2017)

Increased Pro-Inflammatory T Cells, Senescent T Cells, and Immune-Check Point Molecules in the Placentas of Patients With Gestational Diabetes Mellitus
por: Kang, Yea Eun, et al.
Publicado: (2022)

Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice
por: Choung, Sorim, et al.
Publicado: (2019)

Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals
por: Joung, Kyong Hye, et al.
Publicado: (2018)

Effect of cholesterol-lowering agents on soluble epidermal growth factor receptor level in type 2 diabetes and hypercholesterolemia
por: Lee, Jun Choul, et al.
Publicado: (2022)

Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
por: Kong, Sung Hye, et al.
Publicado: (2017)

Efficacy and Safety of High-Dose Atorvastatin in Moderate-to-High Cardiovascular Risk Postmenopausal Korean Women with Dyslipidemia
por: Moon, Jaecheol, et al.
Publicado: (2020)

Genetic Analysis of CLCN7 in an Old Female Patient with Type II Autosomal Dominant Osteopetrosis
por: Kim, Seon Young, et al.
Publicado: (2018)

GDF15 Is a Novel Biomarker for Impaired Fasting Glucose
por: Hong, Jun Hwa, et al.
Publicado: (2014)

Serum CD14 concentration is associated with obesity and insulin resistance in non-diabetic individuals
por: Kang, Yea Eun, et al.
Publicado: (2022)

The Eosinophil Count Tends to Be Negatively Associated with Levels of Serum Glucose in Patients with Adrenal Cushing Syndrome
por: Lee, Younghak, et al.
Publicado: (2017)

Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)
por: Kong, Sung Hye, et al.
Publicado: (2017)

Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
por: Zheng, Dongdan, et al.
Publicado: (2015)

Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia
por: Zhang, Wei-Li, et al.
Publicado: (2014)

A comparative evaluation of safety and efficacy of rosuvastatin, simvastatin, and atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia
por: Adsule, Samir Maruti, et al.
Publicado: (2009)

Asymptomatic Secondary Aortoduodenal Fistula Incidentally Diagnosed During a Health Check-up: A Case Report
por: Park, Sang Ki, et al.
Publicado: (2018)

Lotus leaf alleviates hyperglycemia and dyslipidemia in animal model of diabetes mellitus
por: Kim, Ah-Rong, et al.
Publicado: (2013)

Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
por: Choung, Sorim, et al.
Publicado: (2018)

2018 Guidelines for the management of dyslipidemia
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis
por: Chung, Hyo Kyun, et al.
Publicado: (2017)

A Novel PHEX Gene Mutation in a Patient with Sporadic Hypophosphatemic Rickets
por: Kang, Yea Eun, et al.
Publicado: (2014)

Plasma Adiponectin Levels in Elderly Patients with Prediabetes
por: Kong, Si Eun, et al.
Publicado: (2015)

Prevalence, awareness, treatment, and control of dyslipidemia among diabetes mellitus patients and predictors of optimal dyslipidemia control: results from the Korea National Health and Nutrition Examination Survey
por: Kim, Seung Jae, et al.
Publicado: (2021)

A Retrospective Study on the Efficacy of a Ten-Milligram Dosage of Atorvastatin for Treatment of Hypercholesterolemia in Type 2 Diabetes Mellitus Patients
por: Kim, Dong Kyun, et al.
Publicado: (2010)

2018 Guidelines for the Management of Dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

2018 Guidelines for the management of dyslipidemia in Korea
por: Rhee, Eun-Jung, et al.
Publicado: (2019)

Overview of growth differentiation factor 15 in metabolic syndrome
por: Asrih, Mohamed, et al.
Publicado: (2023)

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017)

T-cell senescence contributes to abnormal glucose homeostasis in humans and mice
por: Yi, Hyon-Seung, et al.
Publicado: (2019)

Effect of Atorvastatin and Clopidogrel Co-Administration After Coronary Stenting in Korean Patients With Stable Angina
por: Kim, Goeng Bae, et al.
Publicado: (2011)

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
por: Kimura, Genjiro, et al.
Publicado: (2016)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
por: Jung, Hae Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4a304ko68lf4tm7nlkt5hjm5de